ML290 is a biased allosteric agonist at the relaxin receptor RXFP1
Abstract Activation of the relaxin receptor RXFP1 has been associated with improved survival in acute heart failure. ML290 is a small molecule RXFP1 agonist with simple structure, long half-life and high stability. Here we demonstrate that ML290 is a biased agonist in human cells expressing RXFP1 wi...
Guardado en:
Autores principales: | Martina Kocan, Mohsin Sarwar, Sheng Y. Ang, Jingbo Xiao, Juan J. Marugan, Mohammed A. Hossain, Chao Wang, Dana S. Hutchinson, Chrishan S. Samuel, Alexander I. Agoulnik, Ross A. D. Bathgate, Roger J. Summers |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dd60bf90c42d4a01bd40b123afd44a23 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The complex binding mode of the peptide hormone H2 relaxin to its receptor RXFP1
por: Ashish Sethi, et al.
Publicado: (2016) -
Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS.
por: Bryna Suet Man Chow, et al.
Publicado: (2012) -
Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin
por: Shoni Bruell, et al.
Publicado: (2017) -
Development of a selective agonist for relaxin family peptide receptor 3
por: Dian Wei, et al.
Publicado: (2017) -
Acta Nº290
por: Banco Central de Chile
Publicado: (2019)